Pereira Thiago Scremin Boscolo, Boscolo Camila Nomura Pereira, Moreira Renata Guimarães, Batlouni Sergio Ricardo
,.
Medical School FACERES, ,.
Anim Reprod. 2018 Aug 16;15(1):64-70. doi: 10.21451/1984-3143-2017-AR983.
Several studies have been developed to support the replacement of the crude carp pituitary extract (CPE) by synthetic products for induced reproduction of South American rheophilic species. However, results have been quite heterogeneous and there is no consensus or a routine use of synthetic products in these species. Thus, the aim of this study was to evaluate the ovulatory process in using different protocols of hormonal induction. Thus, fifteen wild mature females maintained at the Experimental Fish Station, Salto Grande, SP, Brazil were submitted to three different hormonal treatments: CPE (fractioned dose: 0.5 and 5.0 mg kg); mGnRHa (single dose: 3.5 µg kg) and mGnRHa (single dose: 5.0 µg kg). The spawning rate and absolute fecundity were similar among the treatments, but fertility rates were higher for CPE treatment (23.60 ± 9.40) then for mGnRHa treatments (close to or zero zero). Although females ovulated in all treatments, none of them provided viable embryos, showing hatching rates close to zero or zero. Both mGnRHa treatments were more potent for inducing the ovulatory process then CPE treatment, which was evidenced by the fact that the formers showed higher volume density of postovulatory follicles (POF). Accordingly, E and 17α-OHP plasma levels were higher for the mGnRHa treated females compared to the CPE one at the time of ovulation. In this study we confirmed previous scientific evidence that, regardless of whether promoting ovulation, the use of conventional CPE and GnRH doses are not appropriate for some South American migratory species, due to the non-attainment of viable embryos. Moreover, we have brought new information about the relationship between reproductive performance and gonadal steroids concentrations using different hormonal therapies, contributing to understand the reasons for embryo loss in induced spawning.
已经开展了多项研究来支持用合成产品替代粗制鲤鱼垂体提取物(CPE),以诱导南美喜流水鱼类的繁殖。然而,结果差异很大,对于这些鱼类使用合成产品尚未达成共识,也没有常规用法。因此,本研究的目的是使用不同的激素诱导方案评估排卵过程。为此,将15只饲养在巴西圣保罗州萨尔托格兰德实验鱼站的野生成熟雌性鱼进行三种不同的激素处理:CPE(分次剂量:0.5和5.0毫克/千克);促性腺激素释放激素类似物(mGnRHa,单次剂量:3.5微克/千克)和促性腺激素释放激素类似物(单次剂量:5.0微克/千克)。各处理之间的产卵率和绝对繁殖力相似,但CPE处理的受精率较高(23.60±9.40),而促性腺激素释放激素类似物处理的受精率接近或为零(0)。尽管所有处理中的雌性鱼都排卵了,但没有一条产生可存活的胚胎,孵化率接近或为零。两种促性腺激素释放激素类似物处理诱导排卵过程的效力均高于CPE处理,这一点可由前者排卵后卵泡(POF)的体积密度较高得到证明。相应地,促性腺激素释放激素类似物处理的雌性鱼在排卵时的血浆雌二醇(E)和17α-羟孕酮(17α-OHP)水平高于CPE处理的雌性鱼。在本研究中,我们证实了先前的科学证据,即无论是否促进排卵,使用传统的CPE和促性腺激素释放激素(GnRH)剂量对于一些南美洄游鱼类并不合适,因为无法获得可存活的胚胎。此外,我们提供了关于使用不同激素疗法时生殖性能与性腺类固醇浓度之间关系的新信息,有助于理解诱导产卵中胚胎损失的原因。